After Leaping 58% Hygeia Healthcare Holdings Co., Limited (HKG:6078) Shares Are Not Flying Under The Radar

Hygeia Healthcare Holdings Co., Limited (HKG:6078) shareholders are no doubt pleased to see that the share price has bounced 58% in the last month, although it is still struggling to make up recently lost ground. Unfortunately, the gains of the last month did little to right the losses of the last year with the stock still down 44% over that time.

After such a large jump in price, Hygeia Healthcare Holdings may be sending very bearish signals at the moment with a price-to-earnings (or "P/E") ratio of 36.1x, since almost half of all companies in Hong Kong have P/E ratios under 8x and even P/E's lower than 5x are not unusual. However, the P/E might be quite high for a reason and it requires further investigation to determine if it's justified.

Recent times have been advantageous for Hygeia Healthcare Holdings as its earnings have been rising faster than most other companies. The P/E is probably high because investors think this strong earnings performance will continue. If not, then existing shareholders might be a little nervous about the viability of the share price.

See our latest analysis for Hygeia Healthcare Holdings

pe
SEHK:6078 Price Based on Past Earnings April 13th 2022
Keen to find out how analysts think Hygeia Healthcare Holdings' future stacks up against the industry? In that case, our free report is a great place to start.
Advertisement

Does Growth Match The High P/E?

Hygeia Healthcare Holdings' P/E ratio would be typical for a company that's expected to deliver very strong growth, and importantly, perform much better than the market.

Retrospectively, the last year delivered an exceptional 88% gain to the company's bottom line. Pleasingly, EPS has also lifted 7,532% in aggregate from three years ago, thanks to the last 12 months of growth. Accordingly, shareholders would have probably welcomed those medium-term rates of earnings growth.

Turning to the outlook, the next three years should generate growth of 33% each year as estimated by the six analysts watching the company. Meanwhile, the rest of the market is forecast to only expand by 15% each year, which is noticeably less attractive.

In light of this, it's understandable that Hygeia Healthcare Holdings' P/E sits above the majority of other companies. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.

The Key Takeaway

Shares in Hygeia Healthcare Holdings have built up some good momentum lately, which has really inflated its P/E. Using the price-to-earnings ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.

As we suspected, our examination of Hygeia Healthcare Holdings' analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E. Right now shareholders are comfortable with the P/E as they are quite confident future earnings aren't under threat. Unless these conditions change, they will continue to provide strong support to the share price.

There are also other vital risk factors to consider before investing and we've discovered 1 warning sign for Hygeia Healthcare Holdings that you should be aware of.

If P/E ratios interest you, you may wish to see this free collection of other companies that have grown earnings strongly and trade on P/E's below 20x.

Valuation is complex, but we're here to simplify it.

Discover if Hygeia Healthcare Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SEHK:6078

Hygeia Healthcare Holdings

Offers oncology healthcare services in the People's Republic of China.

Adequate balance sheet with moderate growth potential.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0774.4% undervalued
213 users have followed this narrative
1 users have commented on this narrative
30 users have liked this narrative
SI
SimpleMan887
GME logo
SimpleMan887 on GameStop ·

GameStop will ace the financial crisis wave with its strategic Bitcoin investment and cash reserves

Fair Value:US$22089.4% undervalued
53 users have followed this narrative
2 users have commented on this narrative
21 users have liked this narrative
YI
HSAI logo
yiannisz on Hesai Group ·

The First Real Lidar Winner

Fair Value:US$27.0716.3% undervalued
14 users have followed this narrative
1 users have commented on this narrative
4 users have liked this narrative
TR
tripledub
TSM logo
tripledub on Taiwan Semiconductor Manufacturing ·

The Most Wonderful Monopoly in the Most Dangerous Neighbourhood on Earth

Fair Value:US$3812.7% undervalued
10 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

AS
AstrisCorporateAdvisory
9556 logo
AstrisCorporateAdvisory on INTLOOP ·

Renewed focus on business investment

Fair Value:JP¥4.17k56.4% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GO
NLBR logo
GoranLagea on Nova Ljubljanska Banka d.d ·

Nova Ljubljanska Banka d.d. future looks bright with a profit margin change of 38%

Fair Value:€36036.7% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
FA
FIBRO logo
FA_Trader on Fibromat (M) Berhad ·

Fibromat: More than just a niche player, with clearer earnings visibility from order book and project wins

Fair Value:RM 1.0519.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3956.1% undervalued
44 users have followed this narrative
3 users have commented on this narrative
42 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3136.9% undervalued
1350 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.1k% overvalued
36 users have followed this narrative
11 users have commented on this narrative
31 users have liked this narrative